Xpress Biologics is a biopharmaceutical Contract Service Organization (CSO) that specialises in the design of expression systems, process development, and manufacturing of new biologics, including recombinant proteins, antibody fragments, and plasmid DNA. They also focus on the production of biosimilars and biobetters, alongside the management of pre-clinical and clinical trials, as well as Good Manufacturing Practice (GMP) manufacturing. Founded in 2014, Xpress Biologics serves the human and veterinary healthcare markets, with applications in vaccines and therapeutics, as well as diagnostics for in vitro diagnostics (IVD) and medical imaging.

Services include:
– Design of expression systems (bacteria & yeasts)
– Process development for biologics
– Manufacturing of recombinant proteins
– Production of antibody fragments
– Plasmid DNA manufacturing
– Development and production of biosimilars
– Development and production of biobetters
– Management of pre-clinical trials
– Management of clinical trials
– GMP manufacturing

Xpress Biologics is committed to delivering high-quality services tailored to the pharmaceutical industry. For more information, visit xpress-biologics.com.